GO
Loading...

Enter multiple symbols separated by commas

Medicine

More

  • *More than 24 mln birds affected by flu virus- USDA. CHICAGO, May 5- The U.S. government approved the use of an additional $330 million in emergency funds to help contain the worst avian influenza outbreak in U.S. history, as infected bird cases soared and hundreds of Minnesota poultry workers learned they would lose their jobs. Agriculture Secretary Tom Vilsack's...

  • FRANKFURT, May 5- German genetic tests maker Qiagen NV reported a 4 percent fall in adjusted quarterly net profit as U.S. sales of its human papillomavirus test declined and the dollar strengthened, eroding the value of revenues in Europe. Qiagen said on Tuesday that U.S. sales of its HPV test, previously one of its main profit drivers, fell 54 percent due to lower...

  • IBM's Watson to guide cancer therapies at 14 centers Tuesday, 5 May 2015 | 2:00 PM ET

    NEW YORK, May 5- Fourteen U.S. and Canadian cancer institutes will use International Business Machines Corp's Watson computer system to choose therapies based on a tumor's genetic fingerprints, the company said on Tuesday, the latest step toward bringing personalized cancer treatments to more patients. Faced with such a data deluge, "the solution is going to be...

  • HARTFORD, Conn.— The health insurer Aetna is ending most coverage of hysterectomies performed with a once-popular device that has drawn warnings from federal regulators over a risk for spreading cancer. Aetna Inc. will make exceptions for pre-menopausal women who want to maintain their fertility and for whom another treatment would not be effective.

  • May 4- Corbus Pharmaceuticals Holdings Inc's experimental drug for cystic fibrosis, a rare lung-scarring disease, could be a real money spinner and pose a challenge to rival Vertex Pharmaceuticals Inc's successful treatment, Kalydeco. Corbus, a tiny biopharmaceutical company, received $5 million from the Cystic Fibrosis Foundation last month to develop...

  • U.S. top court rejects hepatitis B drug patent case Monday, 4 May 2015 | 9:40 AM ET

    WASHINGTON, May 4- The U.S. Supreme Court on Monday brought to an end Bristol-Myers Squibb Co's attempt to revive patent protection for its Baraclude treatment for hepatitis B. The high court declined to hear Bristol-Myers' challenge to an appeals court ruling in favor of generic rival Teva Pharmaceutical Industries Ltd, which had successfully challenged the...

  • WICHITA, Kan.— Farmers and other agriculture industry leaders will fan out across Kansas in the coming days to examine the extent of damage to winter wheat from drought, disease and winterkill. Reports of a heavy infestation of the disease have surfaced in southeast Kansas near Altamont and more moderate cases have also surfaced in Labette around Labette...

  • DES MOINES, Iowa— It's been five months since the H5N2 bird flu virus was discovered in the United States, and producers have lost 21 million birds in the Midwest alone. Scientists at the U.S. Department of Agriculture, the Centers for Disease Control and Prevention and other federal agencies are puzzled by the H5N2 virus' spread— even amid heightened biosecurity...

  • CHICAGO, May 1- Iowa Governor Terry Branstad declared a state of emergency on Friday due to a rapidly expanding avian flu outbreak, soon after state agriculture officials announced four new poultry farms had initially tested positive for the virus. Iowa, the top egg-producing state in the United States, is the third state to declare a state of emergency because...

  • CHICAGO, May 1- Hog farmers are six times more likely than the general population to carry an infectious bacteria that can cause skin and respiratory problems and resists treatment from multiple drugs, according to a new U.S. research study. The study, published this week in the online journal Clinical Infectious Diseases, is the largest-ever examination of...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. The egg farm's owner, Rembrandt Foods, one of the top U.S. egg producers, confirmed the outbreak but disputed the number of birds affected.

  • Tandem Diabetes reports 1Q loss Thursday, 30 Apr 2015 | 7:09 PM ET

    SAN DIEGO _ Tandem Diabetes Care Inc. on Thursday reported a loss of $21.2 million in its first quarter. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share. This story was generated by Automated Insights using data from Zacks Investment Research.

  • April 30- The U.S. Food and Drug Administration on Thursday approved The Medicines Co's dry powder blood-clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The approval comes at a time Medicines Co is facing a drop in sales of its lead product, Angiomax anticoagulant injection, which accounted for over 80...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. Avian flu was "probable" at four other commercial farms in Buena Vista, Sioux and Clay counties, the Iowa Department of Agriculture and Land...

  • FDA approves Medicines Co's blood clotting agent Thursday, 30 Apr 2015 | 5:47 PM ET

    April 30- The U. S Food and Drug Administration approved the Medicines Co's dry powder blood clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The treatment, Raplixa, is a combination of two human plasma-derived blood-clotting proteins, fibrinogen and thrombin. Raplixa is used to control bleeding during...

  • LOS ANGELES, April 30- Gilead Sciences Inc said on Thursday its quarterly net profit nearly doubled, driven by sales of its novel hepatitis C drugs, as it topped Wall Street estimates. Excluding one-time items, Gilead earned $2.94 per share in the first quarter, outpacing the average Wall Street estimate of $2.32, according to Thomson Reuters I/B/E/S.

  • FOSTER CITY, Calif.— Gilead Sciences raked in $3.6 billion from sales of its newest hepatitis C pill, lifting the drugmaker's results past Wall Street expectations. Gilead Sciences Inc. said Thursday that its net income nearly doubled, and excluding one-time charges it reported a profit of $2.94 per share. Analysts expected net income of $2.31 per share on $6.76...

  • CHICAGO, April 30- An Iowa-based chicken broiler breeding farm has initially tested positive for the highly pathogenic H5 bird flu, the Iowa Department of Agriculture and Land Stewardship confirmed on Thursday. The facility in Kossuth County, Iowa, houses an estimated 19,000 birds, state officials said. The H5N2 strain has been reported in Arkansas, Idaho, Iowa,...

  • NEW YORK— Shares of Blueprint Medicines rose Thursday after the biotech cancer drug developer's initial public offering raised $146.6 million, above its expectations. Blueprint Medicines hopes to start human testing of two drugs this year. Blueprint Medicines Corp. initially filed for an IPO valued at up to $100 million.

  • Pharma: No standout performers   Thursday, 30 Apr 2015 | 11:50 AM ET
    Pharma: No standout performers

    The earnings season for pharmaceutical has gone well so far, with the markets being happy with European pharma results, says Suki Virji, news editor at Scrip Intelligence.